Bank of China Limited (601988.SS) vs Eli Lilly and Company (LLY)

See how Bank of China Limited and Eli Lilly and Company differ across market data and performance, so you can decide which asset best fits your strategy.

$1.11
Shanghai
Bank of China Limited is one of China’s largest commercial banks and has one of the country’s strongest international banking networks. It provides corporate banking, personal banking, trade finance, foreign exchange, wealth management, and treasury services. The bank has a long history in cross-border finance and serves Chinese companies, global corporates, governments, and retail clients. Its performance is influenced by Chinese economic growth, international trade, interest-rate spreads, credit quality, currency activity, and government policy.
View Full Page
$1,431.67
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
View Full Page

Key Metrics Comparison

Bank of China Limited601988.SS
Market Cap
$356.284B
Price
$1.11
24h Change
+0.68%
24h Volume
$227.7M
Employees
313,746
Shares Outstanding
N/A
Eli Lilly and CompanyLLY
Market Cap
$1.275T
Price
$1,431.67
24h Change
-0.82%
24h Volume
$3.07M
Employees
50,000
Shares Outstanding
944,818,881

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

Market Share

Share of combined market cap

Market Share
601988.SS
21.8%
LLY
78.2%

Volume Share

Share of combined 24h volume

Volume Share
601988.SS
98.7%
LLY
1.3%

24h Performance

Price change over last 24 hours

24h Performance
601988.SS
0.68%
LLY
-0.82%
Price Comparison
Bank of China Limited
Eli Lilly and Company